Correspondence
Reply to: Ivermectin in COVID-19. Argumentum ad ignorantiam?
Réplica: Ivermectina en COVID-19. ¿Argumentum ad ignorantiam?
M.L. López Reboiro, C. Sardiña González, J. López Castro
Corresponding author
Servicio de Medicina Interna, Hospital Público de Monforte, Lugo, Spain
Read
2055
Timeswas read the article
325
Total PDF
1730
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 1 | 0 | 1 |
| 2025 5 | 23 | 2 | 25 |
| 2025 4 | 22 | 0 | 22 |
| 2025 3 | 23 | 3 | 26 |
| 2025 2 | 23 | 0 | 23 |
| 2025 1 | 18 | 0 | 18 |
| 2024 12 | 21 | 0 | 21 |
| 2024 11 | 23 | 0 | 23 |
| 2024 10 | 28 | 0 | 28 |
| 2024 9 | 22 | 0 | 22 |
| 2024 8 | 20 | 3 | 23 |
| 2024 7 | 19 | 2 | 21 |
| 2024 6 | 14 | 1 | 15 |
| 2024 5 | 19 | 0 | 19 |
| 2024 4 | 17 | 0 | 17 |
| 2024 3 | 14 | 0 | 14 |
| 2024 2 | 11 | 0 | 11 |
| 2024 1 | 12 | 0 | 12 |
| 2023 12 | 12 | 0 | 12 |
| 2023 11 | 22 | 0 | 22 |
| 2023 10 | 23 | 0 | 23 |
| 2023 9 | 19 | 0 | 19 |
| 2023 8 | 13 | 0 | 13 |
| 2023 7 | 23 | 0 | 23 |
| 2023 6 | 17 | 0 | 17 |
| 2023 5 | 26 | 3 | 29 |
| 2023 4 | 14 | 1 | 15 |
| 2023 3 | 21 | 8 | 29 |
| 2023 2 | 11 | 1 | 12 |
| 2023 1 | 21 | 5 | 26 |
| 2022 12 | 24 | 5 | 29 |
| 2022 11 | 22 | 2 | 24 |
| 2022 10 | 19 | 4 | 23 |
| 2022 9 | 15 | 3 | 18 |
| 2022 8 | 18 | 4 | 22 |
| 2022 7 | 24 | 10 | 34 |
| 2022 6 | 20 | 6 | 26 |
| 2022 5 | 26 | 9 | 35 |
| 2022 4 | 25 | 10 | 35 |
| 2022 3 | 26 | 12 | 38 |
| 2022 2 | 23 | 11 | 34 |
| 2022 1 | 41 | 11 | 52 |
| 2021 12 | 30 | 11 | 41 |
| 2021 11 | 17 | 5 | 22 |
| 2021 10 | 13 | 9 | 22 |
| 2021 9 | 32 | 10 | 42 |
| 2021 8 | 35 | 4 | 39 |
| 2021 7 | 44 | 6 | 50 |
| 2021 6 | 49 | 7 | 56 |
| 2021 5 | 27 | 6 | 33 |
| 2021 4 | 78 | 30 | 108 |
| 2021 3 | 70 | 8 | 78 |
| 2021 2 | 99 | 12 | 111 |
| 2021 1 | 126 | 22 | 148 |
| 2020 12 | 97 | 12 | 109 |
| 2020 11 | 34 | 18 | 52 |
| 2020 10 | 78 | 16 | 94 |
| 2020 9 | 66 | 33 | 99 |
Show all
